Inventor
HSU ANN
US24 patents
⚠️ This page may combine multiple inventors who share the name “HSU ANN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMPAX LABORATORIES LLC
14 patentsUS11357733B2Jun 14, 2022
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES LLC20 citations97
US10987313B2Apr 27, 2021
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES LLC29 citations97
US11666538B2Jun 6, 2023
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES LLC16 citations94
US11622941B2Apr 11, 2023
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES LLC16 citations94
US10973769B2Apr 13, 2021
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES LLC28 citations94
US10688058B2Jun 23, 2020
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES LLC32 citations94
US12274793B2Apr 15, 2025
Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES LLC0 citations73
US12178919B2Dec 31, 2024
Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES LLC1 citations73
US12064521B2Aug 20, 2024
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES LLC1 citations73
US12491164B2Dec 9, 2025
Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES LLC0 citations62
US12403099B2Sep 2, 2025
Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES LLC0 citations62
US12303605B2May 20, 2025
Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES LLC0 citations62
US12178918B2Dec 31, 2024
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES LLC0 citations62
US12128141B1Oct 29, 2024
Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES LLC0 citations62
IMPAX LABORATORIES INC
8 patentsUS8377474B2Feb 19, 2013
Controlled release formulations of levodopa and uses thereof
IMPAX LABORATORIES INC48 citations97
US10292935B2May 21, 2019
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES INC30 citations94
US10098845B2Oct 16, 2018
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES INC28 citations94
US9463246B2Oct 11, 2016
Controlled release formulations of levodopa and uses thereof
IMPAX LABORATORIES INC3 citations82
US9089607B2Jul 28, 2015
Controlled release formulations of levodopa and uses thereof
IMPAX LABORATORIES INC5 citations82
US9089608B2Jul 28, 2015
Controlled release formulations of levodopa and uses thereof
IMPAX LABORATORIES INC6 citations82
US9901640B2Feb 27, 2018
Controlled release formulations of levodopa and uses thereof
IMPAX LABORATORIES INC0 citations47
US9533046B2Jan 3, 2017
Controlled release formulations of levodopa and uses thereof
IMPAX LABORATORIES INC0 citations47